gut.bmj1d
Contrasting US and European approaches to colorectal cancer screening: which is best?
2 VA Puget Sound Health Care System and Division of Gastroenterology, Department of Medicine, University of Washington, Seattle, Washington, USA In the recent 1–2 decades, we have seen a considerable ...
gut.bmj1d
IDDF2019-ABS-0194 The role of tocotrienols in the treatment of non-alcoholic steatohepatitis- a meta-analysis
Background Chronic liver diseases (CLD) represent a major public health problem, accounting for significant mortality of more than 1.75 million deaths are attributed to it. Among these, Non-alcoholic ...
gut.bmj2d
A mouse model of acute biliary pancreatitis induced by retrograde pancreatic duct infusion of Na-taurocholate
Department of Surgery, Tufts University School of Medicine and Tufts-New England Medical Center, Boston, MA 02111, USA Dr George Perides, Department of Surgery, Tufts-New England Medical Center, 860 ...
gut.bmj2d
Quality of life measurement in gastrointestinal and liver disorders
Conflict of interest statement.Professor Irvine shares ownership of the copyright, together with McMaster University, of the Inflammatory Bowel Disease Questionnaire (IBDQ). Modern medicine has had a ...
gut.bmj3d
Hepatitis G virus infection in chronic liver disease
a Liver Unit, Department of Medicine, University of Barcelona Medical School, Barcelona, Spain, b Service of Microbiology, Hospital Clínic, Department of Medicine, University of Barcelona Medical ...
gut.bmj4d
Development and validation of a model to predict survival in colorectal cancer using a gradient-boosted machine
Objective The success of treatment planning relies critically on our ability to predict the potential benefit of a therapy. In colorectal cancer (CRC), several nomograms are available to predict ...
gut.bmj4d
Use of the somatostatin analogue octreotide to localise and manage somatostatin-producing tumours
Background—Somatostatin receptor scintigraphy (SRS) and octreotide therapy have both changed the management of gastroenteropancreatic endocrine tumours, but very few data are available on the use of ...
gut.bmj5d
Detection of Barrett’s oesophagus through exhaled breath using an electronic nose device
Timely detection of oesophageal adenocarcinoma (OAC) and even more so its precursor Barrett’s oesophagus (BO) could contribute to decrease OAC incidence and mortality. An accurate, minimally-invasive ...
gut.bmj5d
Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents
Objective Patients with renal failure suffer from symptoms caused by uraemic toxins, possibly of gut microbial origin, as deduced from studies in animals. The aim of the study is to characterise ...
gut.bmj6d
Intestinal ganglioneuromatosis and multiple endocrine neoplasia type 2B: implications for treatment
Dr V V Smith, Histopathology, Camelia Botnar Laboratories, Great Ormond Street Hospital, Great Ormond Street, London WC1N 3JH, UK. Three infants, who presented with intestinal obstruction due to ...
gut.bmj9d
Inflammatory bowel disease and Parkinson’s disease: common pathophysiological links
Inflammatory bowel disease and Parkinson’s disease are chronic progressive disorders that mainly affect different organs: the gut and brain, respectively. Accumulating evidence has suggested a ...
gut.bmj10d
Disrupted spermatogenesis in a metabolic syndrome model: the role of vitamin A metabolism in the gut–testis axis
Objective Effects of the diet-induced gut microbiota dysbiosis reach far beyond the gut. We aim to uncover the direct evidence involving the gut–testis axis in the aetiology of impaired ...